Pfizer’s Revatio flunks paediatric hypertension studyAn attempt by Pfizer to extend the uses of its pulmonary artery hypertension (PAH) drug Revatio into a Share XPfizer’s Revatio flunks paediatric hypertension studyhttps://pharmaphorum.com/news/pfizers-revatio-flunks-paediatric-hypertension-study/
FDA and EMA to work more closely on paediatric drug regulationFDA and EMA hope to streamline development of paediatric plans. Share XFDA and EMA to work more closely on paediatric drug regulationhttps://pharmaphorum.com/news/eu-us-paediatric-launch-parallel/